James V. Cassella
2021
In 2021, James V. Cassella earned a total compensation of $1.5M as Chief Development Officer at Concert Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $258,765 |
|---|---|
| Option Awards | $483,713 |
| Salary | $464,152 |
| Stock Awards | $283,619 |
| Other | $15,558 |
| Total | $1,505,807 |
Cassella received $483.7K in option awards, accounting for 32% of the total pay in 2021.
Cassella also received $258.8K in non-equity incentive plan, $464.2K in salary, $283.6K in stock awards and $15.6K in other compensation.
Rankings
In 2021, James V. Cassella's compensation ranked 7,249th out of 12,415 executives tracked by ExecPay. In other words, Cassella earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,249 out of 12,415 | 42nd |
Division Manufacturing | 3,183 out of 5,505 | 42nd |
Major group Chemicals And Allied Products | 1,409 out of 2,375 | 41st |
Industry group Drugs | 1,254 out of 2,096 | 40th |
Industry Pharmaceutical Preparations | 921 out of 1,546 | 40th |
Source: SEC filing on April 26, 2022.
Cassella's colleagues
We found two more compensation records of executives who worked with James V. Cassella at Concert Pharmaceuticals in 2021.